InSightec has initiated enrollment for clinical trials evaluating its ExAblate 2000 MRI-guided focused-ultrasound treatment system in pain palliation of metastatic bone tumors.
Up to 20 patients will be enrolled in the trial, which will be conducted at Charité Hospital in Berlin and St. Mary's Hospital in London, according to InSightec of Tirat Carmel, Israel.
By AuntMinnie.com staff writers
September 15, 2005
Related Reading
GE, Insightec ink new deal, August 17, 2005
GE partners with Insightec, October 25, 2004
InSightec gets $21 million infusion, September 29, 2004
Copyright © 2005 AuntMinnie.com